Frank, H, et al, “Expanding the reach of evidence-based mental health interventions to private practice: Qualitative assessment using a policy ecology framework”

Hannah E. Frank, Lauren Milgram, Jennifer B. Freeman,
and Kristen G. Benito

Abstract:

Background: Evidence-based interventions (EBIs) for mental health disorders
are underutilized in routine clinical practice. Exposure therapy for anxiety
disorders is one particularly difficult-to-implement EBI that has robust
empirical support. Previous research has examined EBI implementation
determinants in publicly funded mental health settings, but few studies have
examined EBI implementation determinants in private practice settings. Private
practice clinicians likely face unique barriers to implementation, including
setting-specific contextual barriers to EBI use. The policy ecology framework
considers broad systemic determinants, including organizational, regulatory,
social, and political contexts, which are likely relevant to EBI implementation
in private practice settings but have not been examined in prior research.

Methods: Qualitative interviews were conducted to assess private practice
clinicians’ perceptions of EBI implementation determinants using the policy
ecology framework. Clinicians were asked about implementing mental health
EBIs broadly and exposure therapy specifically. Mixed methods analyses
compared responses from clinicians working in solo vs. group private
practice and clinicians who reported high vs. low organizational support for
exposure therapy.

Results: Responses highlight several barriers and facilitators to EBI
implementation in private practice. Examples include determinants related to
organizational support (e.g., colleagues using EBIs), payer restrictions (e.g.,
lack of reimbursement for longer sessions), fiscal incentives (e.g., payment
for attending training), and consumer demand for EBIs. There were notable differences in barriers faced by clinicians who work in group private practices compared to those working in solo practices. Solo private practice clinicians described ways in which their practice setting limits their degree of colleague support (e.g. for consultation or exposure therapy planning), while also allowing for flexibility (e.g. in their schedules and practice location) that may not be available to clinicians in group practice.

Conclusions: Using the policy ecology framework provides a broad
understanding of contextual factors that impact private practice clinicians’ use
of EBIs, including exposure therapy. Findings point to potential implementation
strategies that may address barriers that are unique to clinicians working in
private practice.

Daniels, T, et al, “Associations of Restraint and Seclusion With Race and Ethnicity on an Adolescent Inpatient Psychiatric Service”

Teresa E Daniels, Colleen Victor, Eric M Smith, Christa Belgrave, Erica Robinson,
Jennifer C Wolff, Jeffrey Hunt, Elizabeth H Brannan

Abstract:

There is limited work examining the association of race and ethnicity with restraint and seclusion (R/S) in pediatric inpatient psychiatric units. The present study assessed risk of R/S by race and ethnicity based on a retrospective review of electronic medical records (EMRs) from an adolescent inpatient psychiatric service. Demographic, diagnostic, and R/S data were analyzed for all 1,865 admissions of 1,327 patients from an adolescent unit at a child and adolescent psychiatric hospital from June 2018 to June 2021. R/S occurred in 459 of the admissions. For the purpose of patient privacy and statistical analysis, race was grouped into the following: Black or African American, other (American Indian or Alaskan Native, Asian, multiracial, other), and White. Patients identified as unknown were not included in the analysis. A binary logistic regression with a repeated subject effect regressed R/S onto race and adjusted for age, gender, and length of stay (LOS). There was an overall significant association of R/S and race (χ = 16.81, p < .001), but not ethnicity. In a regression model adjusted for age, gender, and LOS, patients identified as Black or African American were at significantly higher risk of R/S compared with patients identified as White (odds ratio = 1.66, p = .036). There was no significant difference in risk of R/S between patients identified as White vs other. Younger age and longer LOS were also significantly associated with R/S. These findings highlight a critical health care disparity related to race on an inpatient adolescent psychiatry service. There is likely a combination of individual and systemic factors leading to discriminatory practices in the use of R/S. Future work will assess potential associations with diagnosis and child welfare involvement and will examine additional characteristics of R/S. Focus groups held with hospital and community stakeholders will guide next steps to address these findings.

ADHD traits and psychomotor vigilance after 5 nights of experimental sleep and restriction in early adolescence: preliminary results

Taylor G. Christiansen, BA, Victoria O. Dionisos, BS; Gina M. Mason, PhD; David H. Barker, PhD; Daniel P. Dickstein, MD; Mary A. Carskadon, PhD; Jared M. Saletin, PhD

Parent, J, et al, “Family-based treatment for sleep problems in early adolescence: promise of nighttime parenting as a transdiagnostic treatment target”

Justin Parent, Juliana Acosta, & Dana McMakin

Buitron, V, et al, “Sleep disturbance, social functioning, and suicidal ideation among preadolescent children admitted to intensive psychiatric care”

[embeddoc url=”https://bradleycobre.org/wp-content/uploads/2023/06/BUITRON-et-al-Sleep-Disturbance-Social-Functioning-PARENT-at-SLEEP23.pdf” viewer=”google”]

Kunicki, Z, et al, “Prevalence of Comorbid Depression and Insomnia Among Veterans Hospitalized for Heart Failure with Alzheimer Disease and Related Disorders”

Zachary J. Kunicki, Ph.D., Rachel Frietchen, B.S., John E. McGeary, Ph.D., Lan Jiang, M.S., Matthew S. Duprey, Pharm.D., Ph.D., B.C.C.C.P., Thomas Bayer, M.D., Mriganka Singh, M.D., Jennifer M. Primack, Ph.D., Catherine M. Kelso, M.D., M.S., Wen-Chih Wu, M.D., M.P.H, James L. Rudolph, M.D., Melanie L. Bozzay, Ph.D

Abstract:

Objective: To examine prevalence of Alzheimer Disease and related dementias (ADRD) and patient characteristics as a function of comorbid insomnia and/or depression among heart failure (HF) patients discharged from hospitals.

Design: Retrospective cohort descriptive epidemiology study.

Setting: VA Hospitals. Participants: N = 373,897 Veterans hospitalized with heart failure from October 1, 2011 until September 30, 2020.

Measurements: We examined VA and Center for Medicare & Medicaid Services (CMS) coding in the year prior to admission using published ICD-9/10 codes for dementia, insomnia, and depression. The primary outcome was the prevalence of ADRD and the secondary outcomes were 30-day and 365-day mortality.

Results: The cohort were predominantly older adults (mean age = 72 years, SD = 11), male (97%), and White (73%). Dementia prevalence in participants without insomnia or depression was 12%. In those with both insomnia and depression, dementia prevalence was 34%. For insomnia alone and depression alone, dementia prevalence was 21% and 24%, respectively. Mortality followed a similar pattern with highest 30-day and 365-day mortality higher in those with both insomnia
and depression.

Conclusions: These results suggest that persons with both insomnia and depression are at an increased risk of ADRD and mortality compared to persons with one or neither condition. Screening for both insomnia and depression, especially in patients with other ADRD risk factors, could lead to earlier identification of ADRD. Understanding comorbid conditions which may represent earlier signs of ADRD may be critical in the identification of ADRD risk. (Am J Geriatr Psychiatry 2023; 31:428−437)

McGeary, J, et al, “Associating broad and clinically defined polygenic scores for depression with depression‐ related phenotypes.”

John E. McGeary, Chelsie E. Benca-Bachman, Victoria A. Risner, Christopher G. Beevers, Bradnon E. Gibb, & Rohan H. C. Palmer

Abstract:

Twin studies indicate that 30–40% of the disease liability for depression can be attributed to genetic differences. Here, we assess the explanatory ability of polygenic scores (PGS) based on broad- (PGSBD) and clinical- (PGSMDD) depression summary statistics from the UK Biobank in an independent sample of adults (N = 210; 100% European Ancestry) who were extensively phenotyped for depression and related neurocognitive traits (e.g., rumination, emotion regulation, anhedonia, and resting frontal alpha asymmetry). The UK Biobank-derived PGSBD had small associations with MDD, depression severity, anhedonia, cognitive reappraisal, brooding, and suicidal ideation but only the association with suicidal ideation remained statistically significant after correcting for multiple comparisons. Similarly small associations were observed for the PGSMDD but none remained significant after correcting for multiple comparisons. These findings provide important initial guidance about the expected effect sizes between current UKB PGSs for depression and depression-related neurocognitive phenotypes.

 

Jackson, M, et al “Feasibility of a protocol involving psychophysiology and sleep recordings in a partial hospital program for youth with anxiety and OCD”

Jackson, M, Renschler, K, Maron, M, Markowitz, A, Barker, DH, Carskadon, MA, Benito, K, & Righi, G

Renschler, K, et al, “Sleep and fear extinction learning among youth receiving exposure therapy: Preliminary findings from a partial hospital program”

Renschler, K, Jackson, M, Maron, M, Markowitz, A, Barker, DH, Carskadon, MA, Benito, K & Righi, G

Markowitz, A, et al, “Comparing wrist actigraphy to a novel wearable (Actigpatch): Nonparametric activity estimation”

Markowitz, A, Barker, DH, Saletin, JM, Gredvig-Ardito, CA, McGeary, JE, Carskadon, MA

Wrist actigraphy is a standard measure for monitoring naturalistic sleep patterns; however, data quality is compromised if participants remove the device for daily activities (e.g., baths, exercise).

The Actigpatch is a novel, adhesive water-resistant wearable that we have previously demonstrated as comparable to wrist actigraphy for traditional sleep-wake estimation1.

Here we compare assessment of nonparametric activity indexes.